Endogenous neuroprotective mechanisms in early stages of rat parkinsonism

Endogenous neuroprotective mechanisms in early stages of rat parkinsonism

Bibliographic Details
Main Author:	Lui, Nga Ping
Format:	Others
Language:	English
Published:	HKBU Institutional Repository 2011
Subjects:	Neuroprotective agents Parkinson's disease Therapeutic use Treatment
Online Access:	http://repository.hkbu.edu.hk/etd_ra/1251 http://repository.hkbu.edu.hk/cgi/viewcontent.cgi?article=2250&context=etd_ra

Similar Items

Neuroprotective Treatments in Parkinson’s Disease
by: Elif, et al.
Published: (2019-12-01)

Neuroprotection and Neurotransplantation Strategies in Models of Parkinson’s Disease
by: Galpern, Wendy R.
Published: (1996)

The Promise of Neuroprotective Agents in Parkinson’s Disease
by: Judith ePotashkin, et al.
Published: (2011-11-01)

Neuroprotective effects of lycium barbarum extracts in cerebral and retinal ischemia/reperfusion injury
by: Yang, Di, et al.
Published: (2014)

Secondary degeneration after partial optic nerve transection : mechanisms and the neuroprotective effects of lycium barbarum
by: Li, Hongying, et al.
Published: (2014)

Neuroprotection from induced glutamate excitotoxicity by Conus brunneus conopeptides in a stroke-related model

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
by: Bridget Martinez, et al.
Published: (2018-01-01)

The molecular mechanism of Chinese medicine Uncaria Rhynchophylla (gouteng) for inducing autophagy and protecting neurons in Parkinson's disease
by: Chen, Leilei
Published: (2015)

The effect of daytime restriction of dietary protein on the nutrient intakes and efficacy of levodopa therapy in Parkinson's disease
by: Paré, Sara
Published: (2010)

Erratum: The promise of neuroprotective agents in Parkinson's disease
by: Stacey E Seidl, et al.
Published: (2013-05-01)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
by: Li-Yuan Wang, et al.
Published: (2019-11-01)

Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats
by: Xiao-Jun Feng, et al.
Published: (2020-05-01)

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease
by: R.K. Chaturvedi, et al.
Published: (2006-05-01)

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s Disease
by: Tian-Jiao Chen, et al.
Published: (2020-12-01)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
by: In Su Kim, et al.
Published: (2012-08-01)

Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
by: Md. Habibur Rahman, et al.
Published: (2020-12-01)

Neuroprotective Properties of Green Tea (<i>Camellia sinensis</i>) in Parkinson’s Disease: A Review
by: Dicson Sheeja Malar, et al.
Published: (2020-08-01)

Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
by: Bárbara Mendes-Pinheiro, et al.
Published: (2019-11-01)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
by: Janusz W. Błaszczyk, et al.
Published: (2018-10-01)

Gene therapy: a promising approach for neuroprotection in Parkinson’s disease?
by: Pamela Valdés, et al.
Published: (2016-12-01)

Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
by: Heng-Chung Kung, et al.
Published: (2021-07-01)

Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson’s Disease: A Comparative Study
by: Lyubka P. Tancheva, et al.
Published: (2020-01-01)

Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
by: Jinghua Liu, et al.
Published: (2015-04-01)

Strategies of neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction
by: Rojas-Martinez, Julio Cesar
Published: (2012)

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
by: Carolina Sportelli, et al.
Published: (2020-06-01)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson’s disease.
by: Marta Raquel Carrola Esteves, et al.
Published: (2015-03-01)

MOLECULAR MARKERS OF ENDOGENOUS NEUROPROTECTION IN THE BRAIN OF RATS WITH EXPERIMENTAL PARKINSON'S DISEASE AND ON THE BACKGROUND OF USING NEW PHARMACOTHERAPY SCHEMES
by: Volodymyr Maramukha
Published: (2020-10-01)

Unraveling neuroprotective and neurodegenerative signals
by: Irving E Vega, et al.
Published: (2016-07-01)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?
by: Moussa B.H. Youdim
Published: (2010-10-01)

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential
by: John P.M. Finberg
Published: (2010-07-01)

Evaluation of effects of the Chinese herbal medicine jia wei liu jun zi granules on the treatment of idiopathic Parkinson's disease : a randomized, double-blind, placebo-controlled pilot study
by: Kum, Wan Fung
Published: (2008)

The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson’s Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy
by: Bing Wang, et al.
Published: (2018-04-01)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
by: Michael Jewett, et al.
Published: (2017-06-01)

Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease
by: M.M. Ferro, et al.
Published: (2007-01-01)

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
by: Isabel Lastres-Becker, et al.
Published: (2005-06-01)

Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease
by: Eoin O′Neill, et al.
Published: (2018-01-01)

In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson’s Disease
by: Jin Gyu Choi, et al.
Published: (2016-01-01)

VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
by: Gianni Cutillo, et al.
Published: (2020-11-01)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
by: Xiaoyan Sheng, et al.
Published: (2021-02-01)

Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease
by: Megan M. Senchuk, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_rhec19jh6kcu5oetcumuh6mu59